HIV Citations List: January, 2017

Literature Citations

1. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (Tar) RNA. Abulwerdi, F.A., M.D. Shortridge, J. Sztuba-Solinska, R. Wilson, S.F.J. Le Grice, G. Varani, and J.S. Schneekloth. Journal of Medicinal Chemistry, 2016. 59(24): p. 11148-11160. PMID[28002966].
[PubMed]. HIV_01_2017.

2. A Novel anti-HIV Immunotherapy to Cure HIV. Ahmad, A. and C.R. Rinaldo. AIDS, 2017. 31(3): p. 447-449. PMID[28079543].
[PubMed]. HIV_01_2017.

3. Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Bosque, A., K.A. Nilson, A.B. Macedo, A.M. Spivak, N.M. Archin, R.M. Van Wagoner, L.J. Martins, C.L. Novis, M.A. Szaniawski, C.M. Ireland, D.M. Margolis, D.H. Price, and V. Planelles. Cell Reports, 2017. 18(5): p. 1324-1334. PMID[28147284].
[PubMed]. HIV_01_2017.

4. Design, Synthesis and anti-HIV-1 RT Evaluation of 2-(Benzyl(4-chlorophenyl)amino)-1-(piperazin-1-yl)ethanone Derivatives. Chander, S., P. Wang, P. Ashok, L.M. Yang, Y.T. Zheng, and M. Sankaranarayanan. Bioorganic & Medicinal Chemistry Letters, 2017. 27(1): p. 61-65. PMID[27894873].
[PubMed]. HIV_01_2017.

5. A Synthesis of (+/-)-Thia-Calanolide A, Its Resolution and in Vitro Biological Evaluation. Chopade, A.U., M.U. Chopade, B.M. Chanda, D.D. Sawaikar, K.B. Sonawane, and M.K. Gurjar. Arabian Journal of Chemistry, 2016. 9: p. S1597-S1602. ISI[000390879400091].
[WOS]. HIV_01_2017.

6. Nevirapine Loaded Core Shell Gold Nanoparticles by Double Emulsion Solvent Evaporation: In Vitro and in Vivo Evaluation. Dalvi, B.R., E.A. Siddiqui, A.S. Syed, S.M. Velhal, A. Ahmad, A.B. Bandivdekar, and P.V. Devarajan. Current Drug Delivery, 2016. 13(7): p. 1071-1083. PMDI[26777885].
[PubMed]. HIV_01_2017.

7. Novel Diaryltriazines with a Picolinonitrile Moiety as Potent HIV-1 RT Inhibitors: A Patent Evaluation of WO2016059647(A2). Huang, B., Z. Zhou, D. Kang, W. Li, Z. Chen, P. Zhan, and X. Liu. Expert Opinion on Therapeutic Patents, 2017. 27(1): p. 9-15. PMID[27855563].
[PubMed]. HIV_01_2017.

8. Evaluation of Novel Protease Inhibitors against Darunavir-resistant Variants of HIV Type 1. Inoue, M., D. Oyama, K. Hidaka, and M. Kameoka. FEBS Open Bio, 2017. 7(1): p. 88-95. PMID[28097091]. PMCID[PMC5221448].
[PubMed]. HIV_01_2017.

9. Discovery of Novel Piperidine-substituted Indolylarylsulfones as Potent HIV NNRTIs via Structure-guided Scaffold Morphing and Fragment Rearrangement. Li, X., P. Gao, B. Huang, Z. Zhou, Z. Yu, Z. Yuan, H. Liu, C. Pannecouque, D. Daelemans, E. De Clercq, P. Zhan, and X. Liu. European Journal of Medicinal Chemistry, 2017. 126: p. 190-201. PMID[27750153].
[PubMed]. HIV_01_2017.

10. Reactivation of Latent HIV-1 in Latently Infected Cells by Coumarin Compounds: Hymecromone and Scoparone. Li, X., H.X. Zeng, P.F. Wang, L. Lin, L. Liu, P.Y. Zhen, Y.Z. Fu, P.P. Lu, and H.Z. Zhu. Current HIV Research, 2016. 14(6): p. 484-490. ISI[27697031].
[PubMed]. HIV_01_2017.

11. Bioactive Cucurbitane Triterpenoids from the Tubers of Hemsleya penxianensis. Li, Y.D., S.R. Yi, X.B. Sun, X.Y. Zhou, H.Y. Zhang, Y.Q. Wang, J.S. Yang, X.D. Xu, and G.X. Ma. Phytochemistry Letters, 2016. 18: p. 5-9. ISI[000389521800002].
[WOS]. HIV_01_2017.

12. Synergistic Reactivation of Latent HIV-1 Provirus by PKA Activator Dibutyryl-camp in Combination with an HDAC Inhibitor. Lim, H., K.C. Kim, J. Son, Y. Shin, C.H. Yoon, C. Kang, and B.S. Choi. Virus Research, 2017. 227: p. 1-5. PMID[27677464].
[PubMed]. HIV_01_2017.

13. Periconiasins I and J, Two New Cytochalasans from an Endophytic Fungus Periconia sp. Liu, J.M., D.W. Zhang, M. Zhang, X. Liu, R.D. Chen, J.L. Zhao, L. Li, N. Wang, and J.G. Dai. Tetrahedron Letters, 2016. 57(51): p. 5794-5797. ISI[000390518900016].
[WOS]. HIV_01_2017.

14. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-mimetic Compounds. Madani, N., A.M. Princiotto, C. Zhao, F. Jahanbakhshsefidi, M. Mertens, A. Herschhorn, B. Melillo, A.B. Smith, 3rd, and J. Sodroski. Journal of Virology, 2017. 91(3): e01880-16. PMID[27881646]. PMCID[PMC5244334].
[PubMed]. HIV_01_2017.

15. Synthesis and Antiviral Evaluation of Fluorinated Acyclo-nucleosides and Their Phosphoramidates. Mahmoud, S., H. Li, T.R. McBrayer, L. Bassit, S.F. Hammad, S.J. Coats, F. Amblard, and R.F. Schinazi. Nucleosides, Nucleotides and Nucleic Acids, 2017. 36(1): p. 66-82. PMID[27759481].
[PubMed]. HIV_01_2017.

16. Polyoxypregnane Glycosides from the Roots of Marsdenia tenacissima and their anti-HIV Activities. Pang, X., L.P. Kang, X.M. Fang, Y. Zhao, H.S. Yu, L.F. Han, H.T. Li, L.X. Zhang, B.L. Guo, L.Y. Yu, and B.P. Ma. Planta Medica, 2017. 83(1-02): p. 126-134. PMID[27272399].
[PubMed]. HIV_01_2017.

17. Surfactin Derivatives from Micromonospora sp. CPCC 202787 and their anti-HIV Activities. Pang, X., J. Zhao, X. Fang, H. Liu, Y. Zhang, S. Cen, and L. Yu. Journal of Antibiotics, 2017. 70(1): p. 105-108. PMID[27301660].
[PubMed]. HIV_01_2017.

18. Potential Inhibition of HIV-1 Encapsidation by Oligoribonucleotide-dendrimer Nanoparticle Complexes. Parboosing, R., L. Chonco, F.J. de la Mata, T. Govender, G.E. Maguire, and H.G. Kruger. International Journal of Nanomedicine, 2017. 12: p. 317-325. PMID[28115849]. PMCID[PMC5221794].
[PubMed]. HIV_01_2017.

19. Design and in Vivo Characterization of Immunoconjugates Targeting HIV gp160. Pincus, S.H., K. Song, G.A. Maresh, A. Frank, D. Worthylake, H.K. Chung, P. Polacino, D.H. Hamer, C.P. Coyne, M.G. Rosenblum, J.W. Marks, G. Chen, D. Weiss, V. Ghetie, E.S. Vitetta, J.E. Robinson, and S.L. Hu. Journal of Virology, 2017. 91(3): e01360-16. PMID[27795412]. PMCID[PMC5244325].
[PubMed]. HIV_01_2017.

20. Identification of Human anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins. Pincus, S.H., K. Song, G.A. Maresh, D.H. Hamer, D.S. Dimitrov, W. Chen, M.Y. Zhang, V.F. Ghetie, P.Y. Chan-Hui, J.E. Robinson, and E.S. Vitetta. Journal of Virology, 2017. 91(3): e01955-16 . PMID[27852851]. PMCID[PMC5244328].
[PubMed]. HIV_01_2017.

21. IFITM1 Targets HIV-1 Latently Infected Cells for Antibody-dependent Cytolysis. Raposo, R.A., M. de Mulder Rougvie, D. Paquin-Proulx, P.M. Brailey, V.D. Cabido, P.M. Zdinak, A.S. Thomas, S.H. Huang, G.A. Beckerle, R.B. Jones, and D.F. Nixon. JCI Insight, 2017. 2(1): e85811. PMID[28097226]. PMCID[PMC5214598].
[PubMed]. HIV_01_2017.

22. Enhanced Potency of Bivalent Small Molecule gp41 Inhibitors. Sofiyev, V., H. Kaur, B.A. Snyder, P.A. Hogan, R.G. Ptak, P. Hwang, and M. Gochin. Bioorganic & Medicinal Chemistry, 2017. 25(1): p. 408-420. PMID[27908751]. PMCID[PMC5260928].
[PubMed]. HIV_01_2017.

23. Cold Atmospheric Plasma Inhibits HIV-1 Replication in Macrophages by Targeting Both the Virus and the Cells. Volotskova, O., L. Dubrovsky, M. Keidar, and M. Bukrinsky. Plos One, 2016. 11(10): e0165322. PMID[27783659]. PMCID[PMC5081187].
[PubMed]. HIV_01_2017.

24. Discovery of Novel 3-Hydroxypicolinamides as Selective Inhibitors of HIV-1 Integrase-LEDGF/p75 Interaction. Zhang, F.H., B. Debnath, Z.L. Xu, L.M. Yang, L.R. Song, Y.T. Zheng, N. Neamati, and Y.Q. Long. European Journal of Medicinal Chemistry, 2017. 125: p. 1051-1063. PMID[27810592].
[PubMed]. HIV_01_2017.

Patent Citations

25. Preparation of Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Kadow, J.F., B.N. Naidu, M. Patel, and P. Sivaprakasam. Patent. 2017. 2016-IB54048 2017006260: 60pp.

[Patent]. HIV_01_2017.

26. Preparation of Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Kadow, J.F., B.N. Naidu, T. Wang, and Z. Yin. Patent. 2017. 2016-IB54049 2017006261: 82pp.

[Patent]. HIV_01_2017.

27. Use of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Inhibitors for Treatment, Elimination and Eradication of HIV-1 Infection. Schinazi, R.F. and C. Gavengnano. Patent. 2017. 2016-US40694 2017007712: 135pp.

[Patent]. HIV_01_2017.

28. Preparation of Phosphodiamide Compounds as Antiviral Agents. Vachal, P. and Z. Guo. Patent. 2017. 2016-US40606 2017007701: 68pp.

[Patent]. HIV_01_2017.